News RaQualia Pharma Inc.

Equities

4579

JP3967150008

Delayed Japan Exchange Other stock markets 05:59:20 16/07/2024 BST			5-day change	1st Jan Change
635 ^JPY	+2.42%		+5.67%	-7.85%

03-26	RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others.	CI
02-14	RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others.	03-25	CI
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024	02-14	CI
RaQualia Pharma Inc. agreed to acquire FIMECS, Inc. from Nissay Capital No. 11 Investment Limited Partnership and Nissay Capital Co., Ltd. for ¥4.5 billion.	02-13	CI
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	10/08/23	CI
Constipation Pipeline, Clinical Trials, and Key Companies\|Companies-Anji Pharma, Yuhan, Theravance Biopharma	12/06/23	AQ
RaQualia Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	15/05/23	CI
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	14/02/23	CI
RaQualia Pharma Inc. announced that it has received ¥805.6125 million in funding from CVI Investments, Inc.	04/01/23	CI
RaQualia Pharma Inc. announced that it expects to receive Ã‘805.6125 million in funding from CVI Investments, Inc.	19/12/22	CI
Raqualia Pharma Inc. Provides Consolidated Earnings Guidance for Year Ending December 31, 2022	11/11/22	CI
RaQualia Pharma : Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2022 (JGAAP)	15/08/22	PU
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022	15/08/22	CI
RaQualia Pharma : (Delayed)Summary of Consolidated Financial Results for the Fiscal Year Ended December 31, 2021 (JGAAP)	15/02/22	PU
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022	15/02/22	CI
RaQualia Pharma Inc. Provides Earnings Guidance for the Year Ending December 31, 2021	12/11/21	CI
Raqualia Pharma Inc. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2021	12/08/21	CI
RaQualia Pharma Inc. Announces Consolidated Financial Results for the Six Months Ended June 30, 2021	12/08/21	CI
RaQualia Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2021	14/05/21	CI
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	14/05/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News RaQualia Pharma Inc.

Equities

4579

JP3967150008

Summary

Filters